Morpholine → HCID 178453984, compound

HRID 1045201Notes

Reaction equation

HRID 1045201 reaction equation
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.O=[C:8]1[CH2:13][CH2:12][CH:11]([NH:14][C:15](=[O:21])[O:16][C:17]([CH3:20])([CH3:19])[CH3:18])[CH2:10][CH2:9]1.[BH4-].[Na+].O1CCN([C@H]2CC[C@H](NC(=O)[O-])CC2)CC1>CC(C)[O-].[Ti+4].CC(C)[O-].CC(C)[O-].CC(C)[O-].CO>[O:4]1[CH2:5][CH2:6][N:1]([C@@H:8]2[CH2:9][CH2:10][C@H:11]([NH:14][C:15](=[O:21])[O:16][C:17]([CH3:19])([CH3:18])[CH3:20])[CH2:12][CH2:13]2)[CH2:2][CH2:3]1

Participants

7

Procedure

To a mixture of morpholine (4.08 ml) and tert-butyl 4-oxocyclohexylcarbamate (10 g) stirred for 24 hours at room temperature in titanium(IV) isopropoxide (27.5 ml), methanol (10 ml) was added followed by careful addition of sodium borohydride (3.55 g). The reaction mixture was quenched with water, extracted with ether (2×100 mL), dried over magnesium sulfate, filtered and concentrated. The crude product was purified by FC (silica gel 200 g, 30%-100% acetone/hexanes) providing two products, the title compound and trans 4-morpholinocyclohexylcarbamate.

Workup

  1. customThe reaction mixture was quenched with water
  2. extractionextracted with ether (2×100 mL)
  3. dry with materialdried over magnesium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe crude product was purified by FC (silica gel 200 g, 30%-100% acetone/hexanes)
  7. customproviding two products

Sources & evidence

ORD record
ord-79f4ed43701746eb9c76ce6401e90009
Source dataset
uspto-grants-2013_10
Patent number
US08563735B2

Reaction notes

Loading…